1.Exogenous GM3 ganglioside inhibits atherosclerosis via multiple steps: A potential atheroprotective drug: M. Ao, et al.; Pharmacol. Res. 148, 104445 (2019)
2.Ganglioside GM3-Functionalized Reconstituted High-Density Lipoprotein (GM3-rHDL) as a Novel Nanocarrier Enhances Antiatherosclerotic Ef-ficacy of Statins in apoE−/− C57BL/6 Mice: B. Wei, et al.; Pharmaceutics 14, 2534 (2022)
Role of membrane gangliosides in the binding and action of bacterial toxins: P.H. Fishman; J. Membr. Biol. 69, 85 (1982).
Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor: E.G. Bremer, et al.; J. Biol. Chem. 261, 2434 (1986).
Role of GM3-enriched microdomains in signal transduction regulation in T lymphocytes: M. Sorice, et al.; Glycoconj. J. 20, 63 (2004)
Dynamic and structural properties of sphingolipids as driving force to the formation of membrane domains: S. Sonnino, et al.; Chem. Rev. 106, 2111 (2006)
Membrane microdomains and insulin resistance: J. Inokuchi; FEBS Lett. 584,1864 (2010)
Exogenous GM3 ganglioside inhibits atherosclerosis via multiple steps: A potential atheroprotective drug: M. Ao, et al.; Pharmacol. Res. 148, 104445 (2019)